Table 1.
Characteristics of HIV + transplant recipients with moderate or severe HGG.
| Kidney (N = 12) | Liver (N = 8) | |
|---|---|---|
| Age in years (median (IQR*) | 46 (42,52) | 51(49,54) |
| Male gender (N, %) | 8 (67) | 7 (88) |
| Caucasian (N, %) | 7 (58) | 6 (75) |
| HCV co-infection (N, %) | 0 (0) | 5 (63) |
| HBIG use within 1 week post-transplant (N, %) | 0 (0)40 | 3 (38) |
| Donor Age in years (Median, (IQR)) | 40 (28,46) | 40 (26, 52) |
| Living donor (N, %) | 7 (58) | 0 (0) |
| Combined kidney-liver transplant (N, %) | NA | 1(13) |
| Initial calcineurin inhibitor use (N, %) Cyclosporine Tacrolimus None |
2 (17) 10 (48) 0 (0) |
4 (50) 3 (38) 1 (13) |
| Baseline CD4+ T cell count (cell/mm3, media (IQR)) | 522 (342,642) | 331 (261, 548) |
| Baseline HIV RNA detectable (N, %) | (0) | 2 (25) |
| Baseline IgG (mg/dL, median, (IQR)) | 1105 (847, 1293) | 1110 (940, 1729) |
| Follow up post-transplant in years (median (IQR)) | 3.1 (2.4, 4.6) | (0.8, 4.3) |
*
Interquartile range